pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

18,993 catalysts · 18,987 approval · 7,208 phase readout · 5,000 device 510k · 4,728 grant · 3,603 8k filing · 2,000 device pma

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 30 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 1 catalyst2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts2026-11-16: 0 catalysts2026-11-17: 0 catalysts2026-11-18: 0 catalysts2026-11-19: 0 catalysts2026-11-20: 0 catalysts2026-11-21: 0 catalysts2026-11-22: 0 catalysts
view
agendamonth
hide past →
sort
soonestlatesttypesponsoralpha
type: filing×type: approval×clear all
type
  • approval18,987
  • phase readout7,208
  • device 510k5,000
  • grant4,728
  • 8k filing3,603
  • device pma2,000
  • device recall
2,000
  • recall1,126
  • device adverse event1,000
  • earnings585
  • therapy area
    • Ophthalmology5

    Week of Sep 22, 2025

    50
    ›Sep 24, 2025approval339d agoBONDLIDO (LIDOCAINE) — FDA approvalSustained Therapeutics Inc

    Sponsor: MEDRX USA. Form: SYSTEM. Route: TOPICAL

    full page →fda approvals ↗
    ›Sep 24, 2025approval339d agoHEPARIN SODIUM — FDA approvalHEPARIN SODIUM

    Sponsor: PFIZER. Form: INJECTABLE. Route: INJECTION

    full page →HEPARIN SODIUM →fda approvals ↗
    ›Sep 24, 2025approval339d agoVARENICLINE TARTRATE — FDA approvalMylan Pharmaceuticals Inc

    Sponsor: NE RX PHARMA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Sep 25, 2025approval338d agoITOVEBI (INAVOLISIB) — FDA approvalinavolisib

    Sponsor: GENENTECH INC. Form: TABLET. Route: ORAL

    full page →inavolisib →fda approvals ↗
    ›Sep 25, 2025approval338d agoALYFTREK (DEUTIVACAFTOR) — FDA approval(deutivacaftor + tezacaftor + vanzacaftor calcium)

    Sponsor: VERTEX PHARMS INC. Form: TABLET. Route: ORAL

    full page →(deutivacaftor + tezacaftor + vanzacaftor calcium) →fda approvals ↗
    ›Sep 25, 2025approval338d agoTRIKAFTA (COPACKAGED) (ELEXACAFTOR, IVACAFTOR, TEZACAFTOR) — FDA approvalTRIKAFTA (COPACKAGED)

    Sponsor: VERTEX PHARMS INC. Form: TABLET. Route: ORAL

    full page →TRIKAFTA (COPACKAGED) →fda approvals ↗
    ›Sep 25, 2025approval338d agoTRIKAFTA (COPACKAGED) (ELEXACAFTOR, IVACAFTOR, TEZACAFTOR) — FDA approvalTRIKAFTA (COPACKAGED)

    Sponsor: VERTEX PHARMS INC. Form: GRANULES. Route: ORAL

    full page →TRIKAFTA (COPACKAGED) →fda approvals ↗
    ›Sep 25, 2025approval338d agoORKAMBI (IVACAFTOR) — FDA approval(ivacaftor + lumacaftor)

    Sponsor: VERTEX PHARMS INC. Form: GRANULE. Route: ORAL

    full page →(ivacaftor + lumacaftor) →fda approvals ↗
    ›Sep 25, 2025approval338d agoKALYDECO (IVACAFTOR) — FDA approvalVertex, Inc.

    Sponsor: VERTEX PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Sep 25, 2025approval338d agoKALYDECO (IVACAFTOR) — FDA approvalivacaftor

    Sponsor: VERTEX PHARMS INC. Form: GRANULE. Route: ORAL

    full page →ivacaftor →fda approvals ↗
    ›Sep 25, 2025approval338d agoORKAMBI (IVACAFTOR) — FDA approval(ivacaftor + lumacaftor)

    Sponsor: VERTEX PHARMS INC. Form: TABLET. Route: ORAL

    full page →(ivacaftor + lumacaftor) →fda approvals ↗
    ›Sep 25, 2025approval338d agoSYMDEKO (COPACKAGED) (IVACAFTOR) — FDA approvalivacaftor

    Sponsor: VERTEX PHARMS INC. Form: TABLET. Route: ORAL

    full page →ivacaftor →fda approvals ↗
    ›Sep 25, 2025approval338d agoZEPBOUND (TIRZEPATIDE) — FDA approvalZEPBOUND

    Sponsor: ELI LILLY AND CO. Form: SOLUTION. Route: SUBCUTANEOUS

    full page →ZEPBOUND →fda approvals ↗
    ›Sep 25, 2025approval338d agoROBINUL (GLYCOPYRROLATE) — FDA approvalGLYCOPYRROLATE

    Sponsor: HIKMA. Form: INJECTABLE. Route: INJECTION

    full page →GLYCOPYRROLATE →fda approvals ↗
    ›Sep 25, 2025approval338d agoMOUNJARO (TIRZEPATIDE) — FDA approvalZEPBOUND

    Sponsor: ELI LILLY AND CO. Form: SOLUTION. Route: SUBCUTANEOUS

    full page →ZEPBOUND →fda approvals ↗
    ›Sep 25, 2025approval338d agoFENTANYL CITRATE — FDA approvalEffentora

    Sponsor: HIKMA. Form: INJECTABLE. Route: INJECTION

    full page →Effentora →fda approvals ↗
    ›Sep 25, 2025approval338d agoWEZLANA (USTEKINUMAB-AUUB) — FDA approvalWEZLANA

    Sponsor: AMGEN INC. Form: INJECTABLE. Route: INTRAVENOUS, SUBCUTANEOUS

    full page →WEZLANA →fda approvals ↗
    ›Sep 25, 2025approval338d agoWEZLANA (USTEKINUMAB-AUUB) — FDA approvalWEZLANA

    Sponsor: AMGEN INC. Form: INJECTABLE. Route: INTRAVENOUS, SUBCUTANEOUS

    full page →WEZLANA →fda approvals ↗
    ›Sep 25, 2025approval338d agoINLURIYO (IMLUNESTRANT TOSYLATE) — FDA approvalimlunestrant tosylate

    Sponsor: ELI LILLY AND CO. Form: TABLET. Route: ORAL

    full page →imlunestrant tosylate →fda approvals ↗
    ›Sep 25, 2025approval338d agoCEFUROXIME AXETIL — FDA approvalOrchid Pharma Inc

    Sponsor: CHARTWELL RX. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Sep 25, 2025approval338d agoCEFUROXIME AXETIL — FDA approvalOrchid Pharma Inc

    Sponsor: CHARTWELL RX. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Sep 25, 2025approval338d agoCEFUROXIME AXETIL — FDA approvalOrchid Pharma Inc

    Sponsor: CHARTWELL RX. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Sep 25, 2025approval338d agoPALSONIFY (PALTUSOTINE HYDROCHLORIDE) — FDA approvalpaltusotine hydrochloride

    Sponsor: CRINETICS. Form: TABLET. Route: ORAL

    full page →paltusotine hydrochloride →fda approvals ↗
    ›Sep 25, 2025approval338d agoOXYCODONE HYDROCHLORIDE — FDA approvalOXYCODONE HYDROCHLORIDE

    Sponsor: AVANTHI INC. Form: CAPSULE. Route: ORAL

    full page →OXYCODONE HYDROCHLORIDE →fda approvals ↗
    ›Sep 25, 2025approval338d agoOXYCODONE HYDROCHLORIDE — FDA approvalOXYCODONE HYDROCHLORIDE

    Sponsor: AVANTHI INC. Form: CAPSULE. Route: ORAL

    full page →OXYCODONE HYDROCHLORIDE →fda approvals ↗
    ›Sep 25, 2025approval338d agoEVKEEZA (EVINACUMAB-DGNB) — FDA approvalevinacumab

    Sponsor: REGENERON PHARMACEUTICALS. Form: SOLUTION. Route: INJECTION

    full page →evinacumab →fda approvals ↗
    ›Sep 25, 2025approval338d agoRIVAROXABAN — FDA approvalRIVAROXABAN

    Sponsor: LUPIN LTD. Form: FOR SUSPENSION. Route: ORAL

    full page →RIVAROXABAN →fda approvals ↗
    ›Sep 26, 2025approval337d agoHYDROCODONE BITARTRATE — FDA approvalhydrocodone bitartrate ER

    Sponsor: ALVOGEN. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

    full page →hydrocodone bitartrate ER →fda approvals ↗
    ›Sep 26, 2025approval337d agoENOBY (DENOSUMAB-QBDE) — FDA approvalENOBY

    Sponsor: HIKMA PHARMACEUTICALS USA INC. Form: SOLUTION. Route: INJECTION

    full page →ENOBY →fda approvals ↗
    ›Sep 26, 2025approval337d agoFLUOXETINE HYDROCHLORIDE — FDA approvalEli Lilly and Co

    Sponsor: INVENTIA HLTHCARE. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Sep 26, 2025approval337d agoFLUOXETINE HYDROCHLORIDE — FDA approvalEli Lilly and Co

    Sponsor: INVENTIA HLTHCARE. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Sep 26, 2025approval337d agoAMPHETAMINE SULFATE — FDA approvalamfetamine ER

    Sponsor: EPIC PHARMA LLC. Form: TABLET. Route: ORAL

    full page →amfetamine ER →fda approvals ↗
    ›Sep 26, 2025approval337d agoPYRIDOSTIGMINE BROMIDE — FDA approvalBausch Health US LLC

    Sponsor: US ARMY. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Sep 26, 2025approval337d agoOLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalALDACTAZIDE

    Sponsor: MSN. Form: TABLET. Route: ORAL

    full page →ALDACTAZIDE →fda approvals ↗
    ›Sep 26, 2025approval337d agoCAFFEINE CITRATE — FDA approvalCAFFEINE CITRATE

    Sponsor: FRESENIUS KABI USA. Form: SOLUTION. Route: ORAL

    full page →CAFFEINE CITRATE →fda approvals ↗
    ›Sep 26, 2025approval337d agoCELECOXIB — FDA approvalScilex Holding Co

    Sponsor: NANJING. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Sep 26, 2025approval337d agoCELECOXIB — FDA approvalScilex Holding Co

    Sponsor: NANJING. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Sep 26, 2025approval337d agoCELECOXIB — FDA approvalScilex Holding Co

    Sponsor: NANJING. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Sep 26, 2025approval337d agoTIZANIDINE HYDROCHLORIDE — FDA approvalRiconpharma LLC

    Sponsor: ALKEM LABS LTD. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Sep 26, 2025approval337d agoLIDOCAINE HYDROCHLORIDE — FDA approvalLaryng-O-Jet

    Sponsor: COSETTE. Form: JELLY. Route: TOPICAL

    full page →Laryng-O-Jet →fda approvals ↗
    ›Sep 26, 2025approval337d agoAMPHETAMINE SULFATE — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: AMNEAL PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Sep 26, 2025approval337d agoTREMFYA (GUSELKUMAB) — FDA approvalguselkumab

    Sponsor: JANSSEN BIOTECH. Form: INJECTABLE. Route: INJECTION

    full page →guselkumab →fda approvals ↗
    ›Sep 26, 2025approval337d agoTREMFYA (GUSELKUMAB) — FDA approvalguselkumab

    Sponsor: JANSSEN BIOTECH. Form: INJECTABLE. Route: INJECTION

    full page →guselkumab →fda approvals ↗
    ›Sep 26, 2025approval337d agoQVAR REDIHALER (BECLOMETHASONE DIPROPIONATE) — FDA approvalSOLIGENIX, INC.

    Sponsor: NORTON WATERFORD. Form: AEROSOL, METERED. Route: INHALATION

    full page →fda approvals ↗
    ›Sep 26, 2025approval337d agoCALCITONIN-SALMON (CALCITONIN SALMON) — FDA approvalcalcitonin

    Sponsor: AMNEAL. Form: INJECTABLE. Route: INJECTION

    full page →calcitonin →fda approvals ↗
    ›Sep 26, 2025approval337d agoAMPHETAMINE SULFATE — FDA approvalAurolife Pharma LLC

    Sponsor: SUN PHARM INDS INC. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Sep 26, 2025approval337d agoAMPHETAMINE SULFATE — FDA approvalamfetamine ER

    Sponsor: GRANULES. Form: TABLET. Route: ORAL

    full page →amfetamine ER →fda approvals ↗
    ›Sep 26, 2025approval337d agoCLOTIC (CLOTRIMAZOLE) — FDA approvalSun Pharmaceutical Industries Ltd

    Sponsor: CARWIN PHARM ASSOC. Form: SOLUTION/DROPS. Route: OTIC

    full page →fda approvals ↗
    ›Sep 26, 2025approval337d agoULTOMIRIS (RAVULIZUMAB-CWVZ) — FDA approvalAlexion Pharmaceuticals Inc

    Sponsor: ALEXION PHARM. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Sep 26, 2025approval337d agoTACROLIMUS — FDA approvaltacrolimus ER

    Sponsor: BIOCON PHARMA. Form: CAPSULE. Route: ORAL

    full page →tacrolimus ER →fda approvals ↗
    ← prev
    page 331 of 380
    next →
    $VERX14.30+5.46%
    $VERX14.30+5.46%
    $LLY1174.61-0.13%
    $AMGN439.48-0.20%
    $VERX14.30+5.46%
    $VERX14.30+5.46%
    $VERX14.30+5.46%
    $LLY1174.61-0.13%
    $VERX14.30+5.46%
    $PFE28.03-0.96%
    $VERX14.30+5.46%
    $VERX14.30+5.46%
    $AMGN439.48-0.20%
    $LLY1174.61-0.13%
    $CRNX84.85+0.01%
    $AVTR14.66+1.14%
    $LBRX47.73-0.33%
    $SCLX8.8000+25.00%
    $SCLX8.8000+25.00%
    $SCLX8.8000+25.00%
    $AMRX17.54-2.61%
    $SNGX
    $AMRX17.54-2.61%
    $REGN813.63-0.14%
    $AVTR14.66+1.14%